Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)
- Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)
- Accession Number
Drug Drug Description Methoxsalen A furocoumarin used to treat psoriasis and vitiligo. Metyrapone A steroid 11-beta-monooxygenase inhibitor used to test hypothalamic-pituitary ACTH function. Azelastine A histamine H1-receptor antagonist used intranasally to treat allergic and vasomotor rhinitis and in an ophthalmic solution to treat allergic conjunctivitis. Clofibrate A fibric acid derivative used to treat hypertriglyceridemia and high cholesterol. Fomepizole An inhibitor of alcohol dehydrogenase used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning. Isoniazid An antibiotic used to treat mycobacterial infections; most commonly use in combination with other antimycobacterial agents for the treatment of active or latent tuberculosis. Menadione The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification. Nilvadipine For the management of vasospastic angina, chronic stable angina and hypertension. Seratrodast Seratrodast (INN) is a thromboxane receptor antagonist used primarily in the treatment of asthma. Nicotine A stimulatory alkaloid found in tobacco products that is often used for the relief of nicotine withdrawal symptoms and as an aid to smoking cessation. Triclabendazole An anthelmintic drug used to treat fascioliasis. Selegiline A monoamine oxidase inhibitor used to treat major depressive disorder and Parkinson's.
- Drugs & Drug Targets